Status:
COMPLETED
Methodology Issues in a Tailored Light Treatment for Persons With Dementia
Lead Sponsor:
Icahn School of Medicine at Mount Sinai
Collaborating Sponsors:
National Institute on Aging (NIA)
Conditions:
Sleep Disturbances
Depression
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
Tailored light treatment will increase sleep efficiency, reduce depression and reduce agitation scores in those with Alzheimer's disease and related dementia
Detailed Description
In a within subjects, randomized placebo control study, a tailored light treatment will be used for short-term (4 weeks). Outcome measures include sleep measures (actigraphy), and questionnaires probi...
Eligibility Criteria
Inclusion
- mild to moderate Alzheimer's disease and related dementia (ADRD)
Exclusion
- major organ failure,
- major illness,
- history of head injury,
- hypertension or diabetes,
- use psychotropic (sleep aid) medicine, obstructing cataracts, macular degeneration, and blindness
Key Trial Info
Start Date :
January 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 10 2024
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT01816152
Start Date
January 1 2020
End Date
May 10 2024
Last Update
June 4 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Icahn School of Medicine at Mount Sinai
Albany, New York, United States, 12204
2
Icahn School of Medicine at Mount Sinai
New York, New York, United States, 10029